Therapeutics (TGTX) 2025 Earnings Outlook for Investors
TG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
Enhancing budgeting discipline starts with small, repeatable actions. This intro shares practical steps to strengthen daily money management.
16,897 articlesTG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
A biotech stock surged 75% last quarter and drew a new $9 million investment, signaling confidence from sophisticated...
A clear, investor-focused read on what The Trade Desk's Q1 2026 results mean for 2026. Discover growth drivers, margi...
Equity Residential and AvalonBay Communities unveil an all-stock merger valued at roughly $69 billion, forming a nati...
Markets can swing wildly, but your plan shouldn’t. This guide shows how to prepare for a stock market crash coming wi...
A leading robotic-assisted surgery platform maker is drawing long-term investor attention as it grows its recurring r...
As markets wobble in mid-2026, investors seek steady cash flow from blue-chip dividend names. This piece explains how...
In a rare pivot, Xbox's chief executive joins the Federal Reserve’s external AI and jobs task force just days after r...
Looking at Royal Caribbean in 2026, investors want clarity: is it a buy, hold, or sell? This guide breaks down the ca...
The Trade Desk is testing a strategy that could redefine cross-platform audience reach. Audience Unlimited Could Trad...
When Road releases its Q2 results, the transcript hides clues about growth and risk. This guide translates the road 2...
SpaceX is signaling a public debut that could rewrite IPO benchmarks, even as critics warn the proposed governance st...